CAH

197.89

1.04% -2.07

Handel nachbörslich: 197.89

Cardinal Health Inc (CAH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$199.96

Offen:

$199.24

24-Stunden-Volumen:

2.19M

Relative Volume:

0.89

Marktkapitalisierung:

$47.02B

Einnahmen:

$234.31B

Nettoeinkommen (Verlust:

$1.61B

KGV:

29.87

EPS:

6.6243

Netto-Cashflow:

$4.45B

1W Leistung:

-0.06%

1M Leistung:

-3.64%

6M Leistung:

+21.85%

1J Leistung:

+69.79%

1-Tages-Spanne:

$195.54

$199.67

1-Wochen-Bereich:

$195.54

$200.83

52-Wochen-Spanne:

$114.60

$214.93

Cardinal Health Inc Stock (CAH) Company Profile

Firmenname

Cardinal Health Inc

Sektor

Healthcare (1129)

Branche

Medical Distribution (12)

Telefon

(614) 757-3033

Adresse

7000 CARDINAL PLACE, DUBLIN, OH

Mitarbeiter

57,700

Twitter

@cardinalhealth

Nächster Verdiensttermin

2024-11-01

Neueste SEC-Einreichungen

CAH's Discussions on Twitter

Vergleichen Sie CAH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CAH Cardinal Health Inc	197.89	47.51B	234.31B	1.61B	4.45B	6.6243
MCK Mckesson Corporation	809.96	101.58B	387.09B	4.23B	6.01B	32.12
COR Cencora Inc	341.72	67.96B	321.33B	1.57B	3.21B	7.9518
HSIC Henry Schein Inc	77.05	9.11B	12.50B	314.00M	421.00M	2.44
AHG Akso Health Group Adr	1.23	664.53M	2.22M	-5.63M	-1.68M	-0.24

Cardinal Health Inc Stock (CAH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2025-06-03	Hochstufung	Wells Fargo	Equal Weight → Overweight
2025-02-05	Hochstufung	Jefferies	Hold → Buy
2025-01-08	Hochstufung	TD Cowen	Hold → Buy
2025-01-07	Hochstufung	Evercore ISI	In-line → Outperform
2025-01-06	Hochstufung	BofA Securities	Neutral → Buy
2024-12-13	Hochstufung	Wells Fargo	Underweight → Equal Weight
2024-12-04	Fortgesetzt	Mizuho	Outperform
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-02-09	Hochstufung	Argus	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Underweight
2023-07-10	Herabstufung	Evercore ISI	Outperform → In-line
2023-03-31	Eingeleitet	Citigroup	Neutral
2023-02-03	Hochstufung	Robert W. Baird	Neutral → Outperform
2022-11-04	Hochstufung	BofA Securities	Underperform → Neutral
2022-08-22	Fortgesetzt	Morgan Stanley	Overweight
2022-05-26	Herabstufung	Barclays	Overweight → Equal Weight
2022-05-18	Hochstufung	Evercore ISI	In-line → Outperform
2022-04-12	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-04-01	Fortgesetzt	Credit Suisse	Neutral
2021-08-06	Herabstufung	Deutsche Bank	Buy → Hold
2021-08-05	Herabstufung	BofA Securities	Buy → Underperform
2021-05-10	Herabstufung	Robert W. Baird	Outperform → Neutral
2021-01-08	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-11-02	Hochstufung	Barclays	Equal Weight → Overweight
2020-09-25	Hochstufung	Deutsche Bank	Hold → Buy
2020-07-20	Hochstufung	Guggenheim	Neutral → Buy
2020-05-15	Hochstufung	UBS	Neutral → Buy
2020-04-23	Fortgesetzt	Credit Suisse	Neutral
2020-03-20	Hochstufung	BofA/Merrill	Underperform → Buy
2020-02-12	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2019-12-16	Herabstufung	Guggenheim	Buy → Neutral
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-08-27	Herabstufung	Argus	Buy → Hold
2019-08-20	Hochstufung	Guggenheim	Neutral → Buy
2019-04-18	Eingeleitet	Guggenheim	Neutral
2019-01-17	Eingeleitet	UBS	Neutral
2018-11-16	Herabstufung	Leerink Partners	Outperform → Mkt Perform
2018-04-24	Hochstufung	Leerink Partners	Mkt Perform → Outperform
2018-04-02	Hochstufung	Argus	Hold → Buy
2018-03-08	Eingeleitet	Barclays	Equal Weight
2018-02-27	Fortgesetzt	BofA/Merrill	Underperform
2018-01-05	Eingeleitet	Evercore ISI	In-line

Alle ansehen

Cardinal Health Inc Aktie (CAH) Neueste Nachrichten

11:50 AM

Ember LifeSciences, Inc. announced that it has received $16.5 million in funding from Cardinal Health, Inc., Carrier Ventures, Sea Court Capital and other investors - marketscreener.com

11:50 AM

Dec 15, 2025

Adhesive Bandages Market is expected to generate a revenue of USD 4.48 Billion by 2032, Globally, at 3.60% CAGR: Verified Market Research® - GlobeNewswire Inc.

Dec 15, 2025

There's Been No Shortage Of Growth Recently For Cardinal Health's (NYSE:CAH) Returns On Capital - Yahoo Finance UK

Dec 15, 2025

Orion Porfolio Solutions LLC Increases Position in Cardinal Health, Inc. $CAH - MarketBeat

Dec 15, 2025

Nomura Holdings Inc. Acquires 72,525 Shares of Cardinal Health, Inc. $CAH - MarketBeat

Dec 15, 2025

Dec 14, 2025